These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 18258695

  • 1. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.
    Needham M, James I, Corbett A, Day T, Christiansen F, Phillips B, Mastaglia FL.
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1056-60. PubMed ID: 18258695
    [Abstract] [Full Text] [Related]

  • 2. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
    Mastaglia FL, Needham M, Scott A, James I, Zilko P, Day T, Kiers L, Corbett A, Witt CS, Allcock R, Laing N, Garlepp M, Christiansen FT.
    Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
    [Abstract] [Full Text] [Related]

  • 3. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.
    Price P, Santoso L, Mastaglia F, Garlepp M, Kok CC, Allcock R, Laing N.
    Tissue Antigens; 2004 Nov; 64(5):575-80. PubMed ID: 15496200
    [Abstract] [Full Text] [Related]

  • 4. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
    Rojana-udomsart A, Needham M, Luo YB, Fabian V, Walters S, Zilko PJ, Mastaglia FL.
    Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.
    Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia FL.
    J Clin Neurosci; 2008 Dec; 15(12):1350-3. PubMed ID: 18815046
    [Abstract] [Full Text] [Related]

  • 6. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.
    Sivakumar K, Semino-Mora C, Dalakas MC.
    Brain; 1997 Apr; 120 ( Pt 4)():653-61. PubMed ID: 9153127
    [Abstract] [Full Text] [Related]

  • 7. Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.
    Mastaglia FL.
    Acta Myol; 2009 Oct; 28(2):66-71. PubMed ID: 20128139
    [Abstract] [Full Text] [Related]

  • 8. High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.
    Rojana-udomsart A, James I, Castley A, Needham M, Scott A, Day T, Kiers L, Corbett A, Sue C, Witt C, Martinez P, Christiansen F, Mastaglia F.
    J Neuroimmunol; 2012 Sep 15; 250(1-2):77-82. PubMed ID: 22633068
    [Abstract] [Full Text] [Related]

  • 9. Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.
    Suwa Y, Suzuki N, Soga T, Harada R, Shibui A, Kuroda H, Izumi R, Tateyama M, Nakashima I, Sonoo M, Aoki M.
    Intern Med; 2016 Sep 15; 55(23):3521-3524. PubMed ID: 27904121
    [Abstract] [Full Text] [Related]

  • 10. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients.
    Badrising UA, Maat-Schieman ML, van Houwelingen JC, van Doorn PA, van Duinen SG, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, Verschuuren JJ, Wintzen AR.
    J Neurol; 2005 Dec 15; 252(12):1448-54. PubMed ID: 15942703
    [Abstract] [Full Text] [Related]

  • 11. Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study.
    Phillips BA, Cala LA, Thickbroom GW, Melsom A, Zilko PJ, Mastaglia FL.
    Muscle Nerve; 2001 Nov 15; 24(11):1526-34. PubMed ID: 11745956
    [Abstract] [Full Text] [Related]

  • 12. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
    Kierdaszuk B, Berdynski M, Palczewski P, Golebiowski M, Zekanowski C, Kaminska AM.
    Folia Neuropathol; 2015 Nov 15; 53(4):355-66. PubMed ID: 26785370
    [Abstract] [Full Text] [Related]

  • 13. Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.
    Allenbach Y, Benveniste O, Decostre V, Canal A, Eymard B, Herson S, Bloch-Queyrat C, Hogrel JY.
    Neuromuscul Disord; 2012 Nov 15; 22(11):980-6. PubMed ID: 22738680
    [Abstract] [Full Text] [Related]

  • 14. Sporadic inclusion body myositis presenting with severe camptocormia.
    Ma H, McEvoy KM, Milone M.
    J Clin Neurosci; 2013 Nov 15; 20(11):1628-9. PubMed ID: 24055211
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic features of sporadic inclusion body myositis in China.
    Li K, Pu C, Huang X, Liu J, Mao Y, Lu X.
    Neurol Neurochir Pol; 2015 Nov 15; 49(4):245-50. PubMed ID: 26188941
    [Abstract] [Full Text] [Related]

  • 16. Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis.
    Larue S, Maisonobe T, Benveniste O, Chapelon-Abric C, Lidove O, Papo T, Eymard B, Dubourg O.
    J Neurol Neurosurg Psychiatry; 2011 Jun 15; 82(6):674-7. PubMed ID: 20562458
    [Abstract] [Full Text] [Related]

  • 17. Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1.
    Scott AP, Allcock RJ, Mastaglia F, Nishino I, Nonaka I, Laing N.
    Neuromuscul Disord; 2006 May 15; 16(5):311-5. PubMed ID: 16564169
    [Abstract] [Full Text] [Related]

  • 18. Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis.
    Rojana-udomsart A, Mitrpant C, James I, Witt C, Needham M, Day T, Kiers L, Corbett A, Martinez P, Wilton SD, Mastaglia FL.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):174-7. PubMed ID: 23010279
    [Abstract] [Full Text] [Related]

  • 19. Inclusion-body myositis presenting with facial diplegia.
    Ghosh PS, Laughlin RS, Engel AG.
    Muscle Nerve; 2014 Feb 15; 49(2):287-9. PubMed ID: 24038039
    [Abstract] [Full Text] [Related]

  • 20. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.
    Scott AP, Laing NG, Mastaglia F, Needham M, Walter MC, Dalakas MC, Allcock RJ.
    J Neuroimmunol; 2011 Jun 15; 235(1-2):77-83. PubMed ID: 21543121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.